Search

The CFPB Funding Is Under Constitutional Attack. Does the Bureau Survive? Francis "Trip" Riley, Co-Chair of the firm's Consumer Financial Services Litigation Practice, will participate as a speaker during an upcoming RESPRO webinar. This webinar will look at the history leading up to the Community...

Join Saul Ewing as we participate in the largest annual gathering of in-house counsel in the world as a proud sponsor of the Association of Corporate Counsel Annual Meeting 2022. Visit us at Booth #318! Speaking Engagements: Monday, October 24, 2022 2:30 PM - 3:30 PM Length: 60 mins 409 - Pros and...

Saul Ewing is a proud sponsor of the M&A East Conference held by the Philadelphia Chapter of the Association of Corporate Growth. M&A East attracts top strategic and financial dealmakers as well as leading middle market advisors and provides an environment for valuable networking. The conference...

The Consumer Financial Protection Bureau (“CFPB”) is grappling with determining the most effective means of regulating the buy now pay later industry. BNPL allows a consumer to obtain a product or services immediately at the time of purchase and to make installment payments on the purchase over time...

The CFPB is now ready to directly regulate the purveyors of digital consumer marketing. The CFPB new rule clarifies when digital marketers and financial products sellers are subject to consumer protection regulations. Digital marketers that are "materially involved" in the development of content...

RESPA COMPLIANCE: AVOID PESKY SECTION 8 VIOLATIONS Francis "Trip" Riley III, co-chair of the Firm's Consumer Financial Services Litigation Practice, will be speaking during a ALTA Insights webinar on RESPA Compliance. The Consumer Financial Protection Bureau's (CFPB’s) more aggressive approach to...

Washington, D.C., November 24, 2021 – Saul Ewing LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus'...